Literature DB >> 15579441

Hypoxia in renal disease with proteinuria and/or glomerular hypertension.

Tetsuhiro Tanaka1, Toshio Miyata, Reiko Inagi, Toshiro Fujita, Masaomi Nangaku.   

Abstract

Despite the increasing need to identify and quantify tissue oxygenation at the cellular level, relatively few methods have been available. In this study, we developed a new hypoxia-responsive reporter vector using a hypoxia-responsive element of the 5' vascular endothelial growth factor untranslated region and generated a novel hypoxia-sensing transgenic rat. We then applied this animal model to the detection of tubulointerstitial hypoxia in the diseased kidney. With this model, we were able to identify diffuse cortical hypoxia in the puromycin aminonucleoside-induced nephrotic syndrome and focal and segmental hypoxia in the remnant kidney model. Expression of the hypoxia-responsive transgene increased throughout the observation period, reaching 2.2-fold at 2 weeks in the puromycin aminonucleoside model and 2.6-fold at 4 weeks in the remnant kidney model, whereas that of vascular endothelial growth factor showed a mild decrease, reflecting distinct behaviors of the two genes. The degree of hypoxia showed a positive correlation with microscopic tubulointerstitial injury in both models. Finally, we identified the localization of proliferating cell nuclear antigen-positive, ED-1-positive, and terminal dUTP nick-end labeled-positive cells in the hypoxic cortical area in the remnant kidney model. We propose here a possible pathological tie between chronic tubulointerstitial hypoxia and progressive glomerular diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579441      PMCID: PMC1618699          DOI: 10.1016/S0002-9440(10)63249-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

Review 1.  Role of the microvascular endothelium in progressive renal disease.

Authors:  Duk-Hee Kang; John Kanellis; Christian Hugo; Luan Truong; Sharon Anderson; Dontscho Kerjaschki; George F Schreiner; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2002-03       Impact factor: 10.121

2.  Effects of reduction of renal mass on renal oxygen tension and erythropoietin production in the rat.

Authors:  Anumeet Priyadarshi; Sankaridrug Periyasamy; Thomas J Burke; Steven L Britton; Deepak Malhotra; Joseph I Shapiro
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

3.  HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing.

Authors:  M Ivan; K Kondo; H Yang; W Kim; J Valiando; M Ohh; A Salic; J M Asara; W S Lane; W G Kaelin
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

4.  Protective role of nitric oxide in a model of thrombotic microangiopathy in rats.

Authors:  Jing Shao; Toshio Miyata; Koei Yamada; Norio Hanafusa; Takehiko Wada; Katherine L Gordon; Reiko Inagi; Kiyoshi Kurokawa; Toshiro Fujita; Richard J Johnson; Masaomi Nangaku
Journal:  J Am Soc Nephrol       Date:  2001-10       Impact factor: 10.121

5.  Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis.

Authors:  Y Masuda; A Shimizu; T Mori; T Ishiwata; H Kitamura; R Ohashi; M Ishizaki; G Asano; Y Sugisaki; N Yamanaka
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

6.  HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation.

Authors:  F Yu; S B White; Q Zhao; F S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

7.  Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.

Authors:  Y G Kim; S I Suga; D H Kang; J A Jefferson; M Mazzali; K L Gordon; K Matsui; S Breiteneder-Geleff; S J Shankland; J Hughes; D Kerjaschki; G F Schreiner; R J Johnson
Journal:  Kidney Int       Date:  2000-12       Impact factor: 10.612

8.  Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.

Authors:  Duk-Hee Kang; Jeremy Hughes; Marilda Mazzali; George F Schreiner; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

9.  Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1.

Authors:  Duk-Hee Kang; Alison H Joly; Se-Woong Oh; Christian Hugo; Dontscho Kerjaschki; Katherine L Gordon; Marilda Mazzali; J Ashley Jefferson; Jeremy Hughes; Kirsten M Madsen; George F Schreiner; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

10.  Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys.

Authors:  Christian Rosenberger; Stefano Mandriota; Jan Steffen Jürgensen; Michael S Wiesener; Jan H Hörstrup; Ulrich Frei; Peter J Ratcliffe; Patrick H Maxwell; Sebastian Bachmann; Kai-Uwe Eckardt
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

View more
  23 in total

Review 1.  The suffocating kidney: tubulointerstitial hypoxia in end-stage renal disease.

Authors:  Imari Mimura; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2010-09-28       Impact factor: 28.314

2.  Prolyl hydroxylase domain inhibitors: a new era in the management of renal anemia.

Authors:  Yu Kurata; Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Ann Transl Med       Date:  2019-12

Review 3.  Expanding roles of the hypoxia-response network in chronic kidney disease.

Authors:  Tetsuhiro Tanaka
Journal:  Clin Exp Nephrol       Date:  2016-02-09       Impact factor: 2.801

4.  Anthracycline inhibits recruitment of hypoxia-inducible transcription factors and suppresses tumor cell migration and cardiac angiogenic response in the host.

Authors:  Tetsuhiro Tanaka; Junna Yamaguchi; Kumi Shoji; Masaomi Nangaku
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

Review 5.  Diabetic nephropathy: a disorder of oxygen metabolism?

Authors:  Toshio Miyata; Charles van Ypersele de Strihou
Journal:  Nat Rev Nephrol       Date:  2009-12-15       Impact factor: 28.314

Review 6.  Angiogenesis and hypoxia in the kidney.

Authors:  Tetsuhiro Tanaka; Masaomi Nangaku
Journal:  Nat Rev Nephrol       Date:  2013-03-05       Impact factor: 28.314

7.  Early changes with diabetes in renal medullary hemodynamics as evaluated by fiberoptic probes and BOLD magnetic resonance imaging.

Authors:  Elisabete Alcantara dos Santos; Lu-Ping Li; Lin Ji; Pottumarthi Vara Prasad
Journal:  Invest Radiol       Date:  2007-03       Impact factor: 6.016

Review 8.  Hypoxia and the HIF system in kidney disease.

Authors:  Masaomi Nangaku; Kai-Uwe Eckardt
Journal:  J Mol Med (Berl)       Date:  2007-11-20       Impact factor: 4.599

Review 9.  Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element.

Authors:  Stefan Kaluz; Milota Kaluzová; Eric J Stanbridge
Journal:  Clin Chim Acta       Date:  2008-05-09       Impact factor: 3.786

Review 10.  Hypoxia: The Force that Drives Chronic Kidney Disease.

Authors:  Qiangwei Fu; Sean P Colgan; Carl Simon Shelley
Journal:  Clin Med Res       Date:  2016-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.